Abstract:Teklehaimanot Kiros, 1 Eninur Dejen, 1 Mulu Tiruneh, 2 Tegenaw Tiruneh, 1 Tahir Eyayu, 1 Shewaneh Damtie, 1 Kefyalew Amogne 3 1 Department of Medical Laboratory Sciences, College of Health Sciences and School of Medicine, Debre Tabor University, Debre Tabor, Ethiopia; 2 Department of Social and Public Health, College of Health Sciences and School of Medicine, Debre Tabor University, Debre Tabor, Ethiopia; 3 Debre Tabor College of Health Sciences, Debre Tabor, Ethiopia Correspondence: Teklehaimanot Kiros College of Health Sciences and School of Medicine, Debre Tabor University, Debre Tabor, Ethiopia Tel +251911009588 Email tkt0932@gmail.com Background: Tuberculosis (TB) has remained as a top global public health concern of the 21st century. It is the leading cause of morbidity and mortality among people living with human immunodeficiency virus (HIV) worldwide. Objective: The study aimed to investigate the magnitude of pulmonary tuberculosis and its associated factors among HIV-positive patients attending antiretroviral treatment (ART) clinic in Debre Tabor specialized hospital, Northwest, Ethiopia. Methods: A hospital-based cross-sectional study was conducted among 362 HIV-positive adult participants attending the ART clinic from October 1st to December 30th 2019. Socio-demographic data were collected using a pre-tested questionnaire. Sputum was collected aseptically into a sterile and leak-proof container. Following aseptic techniques, each sample was processed using the GeneXpert assay based on the manufacturer's instructions. Similarly, about 3– 5 mL of whole blood was drawn for CD4+ T-cell count and plasma viral load tests following standard blood collection procedures. CD4+ T-cell count was performed using the BD FACS caliber flow cytometry while the plasma viral load was performed by using a quantitative real-time polymerase chain reaction. Then, collected data were double-checked, cleaned and entered into Epi-Info version 7.2.0.1 and exported to SPSS version 20.0 for further statistical analysis. The bivariate and multivariate logistic regression were conducted to address risk factor analysis. The 95%confidence interval with its corresponding cure and adjusted odds ratio was computed. Finally, p-value ≤ 0.05 was considered as a statistically significant association. Results: In this study, the overall prevalence of tuberculosis among HIV-positive patients was 18 [(5%), 95% CI: 2.8– 7.5]. A high viral load (≥ 1000 copies/mL) was positively associated [AOR (95% CI: 6.4 (1.6– 25.7)), p < 0.001] with developing tuberculosis among HIV-positive patients. Conclusion: The prevalence of TB is low among ART-receiving patients in our study site. Keywords: ART, GeneXpert, pulmonary tuberculosis, predictors, sputum, viral load

Pattern of Changes in Some Biochemical Indicators and Prevalence of HIV Seropositive People Co-Infected with Tuberculosis at FMC, Owerri, Imo State

Predictors of tuberculosis treatment outcomes among people living with HIV in some States in Nigeria

Magnitude and Associated Factors of Pulmonary Tuberculosis Among HIV/AIDS Patients Attending Antiretroviral Therapy Clinic at Debre Tabor Specialized Hospital, Northwest Ethiopia, 2019

Impact of Antiretroviral Therapy on Anemia, Hepatotoxicity, and Immune Reconstitution Inflammatory Syndrome in HIV-Tuberculosis Co-Infected Patients

The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi

Prevalence, Epidemiological, and Clinical Profile of Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis in the Coronavirus Disease 2019 Context in Health Facilities in the East Region, Cameroon

Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study

Impact of highly active antiretroviral drug therapy (HAART) on biochemical, hematologic, atherogenic and anthropometric profiles of human immunodeficiency virus patients at a tertiary hospital in Owo, Nigeria

Epidemiology and clinical parameters of adult human immunodeficiency virus/acquired immunodeficiency syndrome at the initiation of antiretroviral therapy in South Eastern Nigeria

Prevalence and determinants of TB/HIV coinfection: the double tragedy of infectious disease burden - a 5-year retrospective study in a tertiary health facility in Enugu State, Nigeria

Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis

REVISITING TUBERCULOSIS (TB) DIAGNOSIS: THE PROSPECT OF URINE LIPOARABINOMANNAN (LAM) ASSAY AS A DIAGNOSTIC TOOL IN PEOPLE LIVING WITH HIV

Incidence and pattern of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in patients on anti-retroviral therapy: An observational study

Deciphering TB-IRIS in HIV Patients: A Comprehensive Clinical and Microbiological Analysis

Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa

Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis

Completion rate of tuberculosis preventive therapy and incidence of tuberculosis among people living with the Human Immunodeficiency Virus on antiretroviral therapy in Ekurhuleni East subdistrict, Gauteng province

The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis

Enhancement of Tuberculosis Detection and Prevention in HIV-Infected Patients

Active tuberculosis disease among people living with HIV on ART who completed tuberculosis preventive therapy at three public hospitals in Uganda

Mycobacterium tuberculosis and human immunodeficiency virus co-infection and associated variables among presumptive pulmonary tuberculosis patients in Ethiopia; a health institution based cross-sectional study